Side-by-side financials for CLRB and NVS. Every figure below comes from audited SEC filings and refreshed market data.
| Metric | CLRB | NVS |
|---|---|---|
| Market cap | - | $283.13 B |
| US-listed rank | - | #47 |
| Net income (latest FY) | -$21.79M | - |
| SEC filings | 1,001 | 947 |
Full pages: Cellectar Biosciences, Inc. and Novartis AG, or browse the full rankings.